Adaptation mechanisms of Clostridioides difficile to auranofin and its impact on human gut microbiota
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Adaptation mechanisms of Clostridioides difficile to auranofin and its impact on human gut microbiota ; volume:10 ; number:1 ; day:17 ; month:9 ; year:2024 ; pages:1-13 ; date:12.2024
npj Biofilms and Microbiomes ; 10, Heft 1 (17.9.2024), 1-13, 12.2024
- Urheber
-
Anjou, Cyril
Royer, Marie
Bertrand, Émilie
Bredon, Marius
Le Bris, Julie
Salgueiro, Iria Alonso
Caulat, Léo C.
Dupuy, Bruno
Barbut, Frédéric
Morvan, Claire
Rolhion, Nathalie
Martin-Verstraete, Isabelle
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41522-024-00551-3
- URN
-
urn:nbn:de:101:1-2411302102591.568398655987
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Anjou, Cyril
- Royer, Marie
- Bertrand, Émilie
- Bredon, Marius
- Le Bris, Julie
- Salgueiro, Iria Alonso
- Caulat, Léo C.
- Dupuy, Bruno
- Barbut, Frédéric
- Morvan, Claire
- Rolhion, Nathalie
- Martin-Verstraete, Isabelle
- SpringerLink (Online service)
Ähnliche Objekte (12)
Applications of Fecal Microbiota Transplantation: Emphasis on Clostridioides difficile Infections
Microbiota-based markers predictive of development of Clostridioides difficile infection
Fecal Microbiota Transplantation Is Effective for Postcolectomy Recurrent Clostridioides difficile Infection
Patient Education: Clostridioides difficile Infection
Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin
Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
Globale genomische Epidemiologie von Clostridioides difficile
Gut metabolites predict Clostridioides difficile recurrence
Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant
Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection
Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition
Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
Applications of Fecal Microbiota Transplantation: Emphasis on Clostridioides difficile Infections
Microbiota-based markers predictive of development of Clostridioides difficile infection
Fecal Microbiota Transplantation Is Effective for Postcolectomy Recurrent Clostridioides difficile Infection
Patient Education: Clostridioides difficile Infection
Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin
Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
Globale genomische Epidemiologie von Clostridioides difficile
Gut metabolites predict Clostridioides difficile recurrence
Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant
Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection
Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition
Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
Applications of Fecal Microbiota Transplantation: Emphasis on Clostridioides difficile Infections
Microbiota-based markers predictive of development of Clostridioides difficile infection
Fecal Microbiota Transplantation Is Effective for Postcolectomy Recurrent Clostridioides difficile Infection
Patient Education: Clostridioides difficile Infection
Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin
Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
Globale genomische Epidemiologie von Clostridioides difficile
Gut metabolites predict Clostridioides difficile recurrence
Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant
Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection
Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition